Ctr9 - CTR9 homolog, Paf1/RNA polymerase II complex component

Predicted to enable RNA polymerase II complex binding activity and SH2 domain binding activity. Predicted to be involved in several processes, including histone modification; negative regulation of RNA metabolic process; and positive regulation of histone modification. Predicted to act upstream of or within blastocyst development and regulation of genetic imprinting. Predicted to be located in nucleoplasm and transcriptionally active chromatin. Predicted to be part of Cdc73/Paf1 complex. Orthologous to human CTR9 (CTR9 homolog, Paf1/RNA polymerase II complex component). [provided by Alliance of Genome Resources, Apr 2022]